G2-PASE approximates PASI using routinely captured PGA and BSA, aiming to replace impractical PASI scoring in real-world clinical settings without sacrificing measurement fidelity. Strong performance ...
STEPIn enrolled systemic- and phototherapy-naïve adults with plaque psoriasis ≤1 year and randomized secukinumab 300 mg versus nb-UVB for 52 weeks, then observed off-treatment to week 104. Off-therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results